These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13622371)

  • 1. [First clinical results of an isoniazid derivative (isonicotinylhydrazone of furyl-2-methyl ketone) in pulmonary tuberculosis].
    PERELLI A
    Minerva Med; 1958 Dec; 49(98 Suppl):4597-606. PubMed ID: 13622371
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic action in pulmonary tuberculosis of a new derivative of nicotinic acid hydrazide: isonicotinylhydrazone of furyl-2-methyl ketone; clinical observations].
    SBRAGIA S
    Minerva Med; 1958 Dec; 49(98 Suppl):4612-22. PubMed ID: 13622373
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical observations in isonicotinylhydrazone of furyl-2-methyl ketone therapy of pulmonary tuberculosis].
    PACILIO G; SCOGNAMILLO A
    Minerva Med; 1958 Dec; 49(98 Suppl):4632-4. PubMed ID: 13622375
    [No Abstract]   [Full Text] [Related]  

  • 4. [Isonicotinylhydrazone of furyl-2-methyl ketone in the treatment of pulmonary tuberculosis].
    PATRONI N; FODDAI G
    Minerva Med; 1958 Dec; 49(98 Suppl):4622-31. PubMed ID: 13622374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isonicotinylhydrazone of furyl-2-methyl ketone].
    GENAZZANI E; PAOLETTI A
    Minerva Med; 1958 Dec; 49(98 Suppl):4591-7. PubMed ID: 13622370
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation with isonicotinylhydrazone of furyl-2-methyl ketone in human pulmonary tuberculosis; 31 cases].
    NOZZOLI F; SUSINI S
    Minerva Med; 1958 Dec; 49(98 Suppl):4606-11. PubMed ID: 13622372
    [No Abstract]   [Full Text] [Related]  

  • 7. [The isonicotinoylhydrazone of 2-furyl methyl ketone in the therapy of pulmonary tuberculosis].
    FOSSATI C
    Gazz Med Ital; 1961 Sep; 120():353-9. PubMed ID: 13894220
    [No Abstract]   [Full Text] [Related]  

  • 8. [The isonicotinoyl-hydrazone of 2-furyl methyl ketone in the therapy of urogenital tuberculosis].
    MARANI F; BIANCO A; TORCELLO V
    Minerva Urol; 1961; 13():106-20. PubMed ID: 13766406
    [No Abstract]   [Full Text] [Related]  

  • 9. [The isonicotonylhydrazone of the furyl-2-methyl ketone in the treatment of female genital tuberculosis].
    DE CECCO L
    Minerva Ginecol; 1960 Feb; 12():143-9. PubMed ID: 13814712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variations in tissue reactivity (determined by intradermoreactions to tuberculin and colchicine) during treatment with the isonicotinoylhydrazone of 2-furyl methyl ketone].
    TARCHIANI G; PACI P
    Minerva Med; 1959 Dec; 50():3914-27. PubMed ID: 13836929
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical observations on th possibility of use in the treatment o pulmonary tuberculosis of a new derivative of isoniazid: 2-carboxybenzaldehydeisonicotinoylhydrazone].
    SBRAGIA S
    Lotta Tuberc; 1960; 30():255-69. PubMed ID: 14442170
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usnic acid from lichens in therapy of tuberculosis].
    PLICHET A
    Presse Med (1893); 1955 Mar; 63(17):350. PubMed ID: 14371514
    [No Abstract]   [Full Text] [Related]  

  • 13. Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy.
    LEITES V
    Am Rev Respir Dis; 1959 Jul; 80(1, Part 1):89-94. PubMed ID: 13670395
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoniazid therapy in pulmonary tuberculosis.
    PITTS FW; MILLER FL; DYE WE; TEMPEL CW; FITZPATRICK MJ
    U S Armed Forces Med J; 1953 Jan; 4(1):1-9. PubMed ID: 13005853
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of a derivative of isoniazid: G 605].
    DUROUX A; MASSON P; MARTY J; JARNIOU A; AZORIN D; MISTROT ; ROBERT
    Rev Tuberc; 1953; 17(10-11):1092-4. PubMed ID: 13135261
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of pulmonary tuberculosis with high alternating dosage of pyrazinamide and isoniazid].
    REALE M; GARAVENTA A; PAOLI G; COSTA G; MORETTI E
    Gazz Med Ital; 1957 Jun; 116(6):245-54. PubMed ID: 13448341
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of three months of combined isoniazid and PAS therapy of pulmonary tuberculosis; comparison with isoniazid therapy alone and with combined isoniazid, streptomycin and PAS].
    BERNARD E; KREIS B; LOTTE A; LEJOUBIOUX E; JULLIEN JL
    Rev Tuberc; 1954; 18(9):841-50. PubMed ID: 14358294
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a synthetic anti-inflammatory drug in the treatment of pleuropulmonary tuberculosis].
    GUILLERMAND J; TIZZANI RJ; SERRADIMIGNI A
    Therapie; 1955; 10(4):591-602. PubMed ID: 13299215
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of isoniazid versus no chemotherapy in the prevention of relapse of chronic cavitary tuberculosis.
    ECKLEY GM; WILSON JL
    Am Rev Respir Dis; 1960 Aug; 82():242-3. PubMed ID: 13725621
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concentration of free isoniazid in the blood of pulmonary tuberculosis patients].
    LESTON JM; DUBRA FA; CETRANGOLO A; PILHEU JA
    Prensa Med Argent; 1961 Jun; 48():1675-80. PubMed ID: 14464371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.